Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-04-21 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
独立董事2023年度述职报告（梅乐和）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2023 Annual Work Report" for Ningbo New Century Biotechnology Co., Ltd. It details the independent director's attendance at board meetings, opinions on various company matters, participation in audit committee meetings, and communication with internal audit and accounting firms. The content focuses on the independent director's duties, opinions, and activities during the year 2023. It is not a financial report, earnings release, or regulatory filing but a detailed report on the independent director's work and governance role. This fits best under Board/Management Information (MANG), which covers announcements related to board or senior management activities and reports. The document length is 3201 characters, which is consistent with a detailed report rather than a brief announcement or certification. Therefore, the classification is MANG with high confidence.
2024-04-21 Chinese
关于公司及子公司向银行申请授信的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's and its subsidiaries' application for bank credit facilities. It details the credit amount, purpose, approval by the board and supervisory committee, and the necessity and impact of the credit application. There is no financial report, earnings data, or detailed financial statements included. The document is a corporate announcement about financing activities, specifically about credit application, which fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the best classification is CAP with high confidence.
2024-03-26 Chinese
第八届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the eighth meeting of the eighth board of directors of Ningbo New Zhi Biotechnology Co., Ltd. It details the meeting's attendance, agenda items, and voting results on various corporate matters such as the proposed cancellation of subsidiaries, bank credit applications, and asset purchases. The document does not contain financial statements or detailed financial analysis but rather reports on board decisions and approvals. It is not an annual or interim report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement. The content fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management. The document length is short (2019 characters), and it is a direct announcement of board resolutions, not a report publication announcement or regulatory filing. Therefore, the appropriate classification is MANG with high confidence.
2024-03-26 Chinese
关于拟注销全资子公司的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from Ningbo New Zhi Biotechnology Co., Ltd. regarding the proposed cancellation (注销) of its wholly-owned subsidiaries. It details the board meeting resolution approving the cancellation, the basic information of the subsidiaries, and the impact of the cancellation on the company. There is no financial data, no mention of annual or interim reports, no audit information, no earnings data, and no regulatory certifications. The document is a corporate announcement about management decisions related to subsidiaries, specifically a board resolution and company operational update. This fits best under the category of Board/Management Information (MANG), which covers announcements of changes in company structure or management decisions. The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2024-03-26 Chinese
第八届监事会第七次决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of Ningbo New Zhi Biotechnology Co., Ltd. It details the meeting date, attendance, and resolutions passed regarding credit application and asset purchase. It does not contain financial statements or detailed financial data but rather formal meeting decisions and approvals. The document length is short (1653 characters) and it serves as an official announcement of board resolutions rather than a full report or financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for announcements that do not fit other specific categories.
2024-03-26 Chinese
高级管理人员辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management personnel (vice general manager) from the company Ningbo New Zhi Biotechnology Co., Ltd. It details the resignation date, shareholding of the resigning person, and the impact of the resignation on the company's board and operations. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no mention of any report publication. The content fits the category of Board/Management Information (MANG) as it announces changes in senior management.
2024-03-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.